BCM
TLSIW icon

Bluefin Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bluefin Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-115,989
Closed -$211K – 150
2024
Q2 		$211K Buy
+115,989
New +$157K 0.05% 65

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bluefin Capital Management's TLSIW Position: Q3 2024 in Review

Bluefin Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 115,989 shares — an estimated $211K sold.

Bluefin Capital Management first reported a position in TLSIW in Q2 2024 and held it in 1 quarter. The position peaked at $211K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • Bluefin Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • Bluefin Capital Management sold 115,989 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $211K.
  • Bluefin Capital Management first reported a position in TriSalus Life Sciences Warrant in Q2 2024 and held it in 1 quarter.
  • Bluefin Capital Management's TriSalus Life Sciences Warrant position peaked at $211K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Bluefin Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.